Correlation Between Passage Bio and Bluebird Bio
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Bluebird bio, you can compare the effects of market volatilities on Passage Bio and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Bluebird Bio.
Diversification Opportunities for Passage Bio and Bluebird Bio
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Passage and Bluebird is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Passage Bio i.e., Passage Bio and Bluebird Bio go up and down completely randomly.
Pair Corralation between Passage Bio and Bluebird Bio
Given the investment horizon of 90 days Passage Bio is expected to generate 0.73 times more return on investment than Bluebird Bio. However, Passage Bio is 1.37 times less risky than Bluebird Bio. It trades about 0.05 of its potential returns per unit of risk. Bluebird bio is currently generating about 0.01 per unit of risk. If you would invest 73.00 in Passage Bio on September 14, 2024 and sell it today you would earn a total of 5.00 from holding Passage Bio or generate 6.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Passage Bio vs. Bluebird bio
Performance |
Timeline |
Passage Bio |
Bluebird bio |
Passage Bio and Bluebird Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Passage Bio and Bluebird Bio
The main advantage of trading using opposite Passage Bio and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Bluebird Bio vs. Mersana Therapeutics | Bluebird Bio vs. Zentalis Pharmaceuticals Llc | Bluebird Bio vs. Y mAbs Therapeutics | Bluebird Bio vs. Travere Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |